Assessment of Patients with Hematuria Hematuria comes in two main varieties: gross and
microscopic. A wide range of ailments can lead to hematuria, and the central task is to rule …

Purpose: Patients presenting with microhematuria represent a heterogeneous population
with a broad spectrum of risk for genitourinary malignancy. Recognizing that patient-specific …

Context Non-visible haematuria (NVH) is a common finding and may indicate undiagnosed
urological cancer. The optimal investigation of NVH is unclear, given the incidence of cancer …

Background Patient factors associated with urinary tract cancer can be used to risk stratify
patients referred with haematuria, prioritising those with a higher risk of cancer for prompt …

Background Stroke-associated pneumonia (SAP) is a serious and common complication in
stroke patients. Purpose We aimed to develop and validate an easy-to-use model for …

Importance Microhematuria (MH) is a common finding that often leads to further evaluation
for urinary tract cancers. There is ongoing debate about the extent to which patients with MH …

Simple Summary In England, patients with alarm features of cancer should be assessed by
a specialist within 14 days based on national guidelines. However, it is not known how …

Background: Hematuria is the most common presenting symptom in bladder cancer, but
many patients are not adequately evaluated. Objectives: To evaluate the type and frequency …

Introduction The vast majority of patients who undergo a diagnostic evaluation for
microscopic hematuria (MH) do not have occult bladder cancer. Identifying patients with MH …

Objectives In urological cancers, sex disparity exists for survival, with women doing worse
than men. Suboptimal evaluation of presenting symptoms may contribute. Design We …